Penella J. Woll

Sheffield, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Large-scale association study identifies lung cancer susceptibility copy number variants and their potential functional role in genetic instability.

Large-scale association study identifies lung cancer susceptibility copy number variants and their potential functional role in genetic instability.

Journal: medRxiv : the preprint server for health sciences

Published: May 25, 2026

Germline HLA heterozygosity is associated with decreased lung cancer risk.

Germline HLA heterozygosity is associated with decreased lung cancer risk.

Journal: HGG advances

Published: October 07, 2025

Genes associated with genetic and rare lung diseases and the risk of lung cancer.

Genes associated with genetic and rare lung diseases and the risk of lung cancer.

Journal: Research square

Published: August 20, 2025

Genes associated with genetic and rare lung diseases and the risk of lung cancer.

Genes associated with genetic and rare lung diseases and the risk of lung cancer.

Journal: BMC cancer

Published: July 02, 2025

Selumetinib in Combination with Anti Retroviral Therapy in HIV-associated Kaposi sarcoma (SCART): an open-label, multicentre, phase I/II trial.

Selumetinib in Combination with Anti Retroviral Therapy in HIV-associated Kaposi sarcoma (SCART): an open-label, multicentre, phase I/II trial.

Journal: BMC cancer

Published: January 08, 2025

Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata.

Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata.

Journal: British journal of cancer

Published: January 26, 2023

Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls.

Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls.

Journal: Cancer

Published: December 07, 2022

Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer risk.

Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer risk.

Journal: Human molecular genetics

Published: November 04, 2022

Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): A randomised, double-blind, placebo-controlled phase II trial.

Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): A randomised, double-blind, placebo-controlled phase II trial.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: March 14, 2022

Gene-gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer.

Gene-gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer.

Journal: European journal of medical research

Published: September 07, 2021

Integration of multiomic annotation data to prioritize and characterize inflammation and immune-related risk variants in squamous cell lung cancer.

Integration of multiomic annotation data to prioritize and characterize inflammation and immune-related risk variants in squamous cell lung cancer.

Journal: Genetic epidemiology

Published: June 05, 2020

Oncolytic herpesvirus therapy for mesothelioma - A phase I/IIa trial of intrapleural administration of HSV1716.

Oncolytic herpesvirus therapy for mesothelioma - A phase I/IIa trial of intrapleural administration of HSV1716.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 28, 2020

Showing 1-12 of 61

Last Updated: 09/26/2026